162330-18-9

Basic information

• Product Name: 4-(bromomethyl)-N-(tert-butyl)benzamide
• Synonyms: 4-(bromomethyl)-N-(tert-butyl)benzamide
• CAS NO: 162330-18-9
• Molecular Weight: 270.169
• Mol File: 162330-18-9.mol

Chemical Properties

• CAS DataBase Reference: 4-(bromomethyl)-N-(tert-butyl)benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(bromomethyl)-N-(tert-butyl)benzamide(162330-18-9)
• EPA Substance Registry System: 4-(bromomethyl)-N-(tert-butyl)benzamide(162330-18-9)

Safety Data

• Hazardous Substances Data: 162330-18-9(Hazardous Substances Data)

Upstream product

• 42498-32-8 N-tert-butyl-4-methylbenzamide 
• 6232-88-8 4-bromomethylbenzoic Acid 
• 52780-16-2 4-bromomethylbenzoyl chloride 
• 75-64-9 tert-butylamine 

Downstream Products

• 162329-95-5 (E)-N-tert-butyl-4-<2-(1,2-dihydro-1-methyl-2-oxopyridine-5-yl)ethenyl>benzamide 
• 162329-96-6 (E)-N-tert-butyl-4-<2-(1,2-dihydro-1-methyl-2-oxopyridine-5-yl)-2-methylethenyl>benzamide 
• 1161399-44-5 PtMe₂(4,4'-di-tert-butyl-2,2'-bipyridine)Br(CH₂-4-C₆H₄CONH-t-Bu) 

Relevant articles and documents

2,3-diketone indole compound, preparation method and applications thereof

The invention discloses a 2,3-diketone indole compound, a preparation method and applications thereof, wherein the compound has a structure represented by the following general formula (I) or (II). The invention further relates to a pharmaceutical composi

5-methyl-1H-pyrazole derivative, preparation method and applications thereof

The invention discloses a 5-methyl-1H-pyrazole derivative, a preparation method and applications thereof, wherein the compound has a structure represented by a general formula (I). The invention further provides the preparation method and the applications

Discovery of novel 5-methyl-1H-pyrazole derivatives as potential antiprostate cancer agents: Design, synthesis, molecular modeling, and biological evaluation

Androgen receptor (AR) signaling functions as a core driving force for the progression of prostate cancer (PCa), and AR has been proved to be an effective therapeutic target even for castration-resistant prostate cancer (CRPC). Herein, structural modification via a fragments splicing strategy was performed based on two lead compounds T3 and 10e, leading to the discovery of a series of 5-methyl-1H-pyrazole derivatives. AR reporter gene assay revealed compounds A13 and A14 as potent AR antagonists. Some of the compounds in this series inhibited growth of PCa LNCaP cells more efficiently than enzalutamide. A13 and A14 also showed improved metabolic stability compared with 10e in human liver microsomes.

Novel 5α-reductase inhibitors. Synthesis and structure-activity studies of 5-substituted 1-methyl-2-pyridones and 1-methyl-2-piperidones

In search for nonsteroidal inhibitors of 5α-reductase for the treatment of benign prostatic hyperplasia (BPH) and possibly prostate cancer, substrate mimicks were synthesized comprising of a 1-methyl-2-pyridone (2, 4-16) or 1-methyl-2-piperidone (1, 3, 17